Reorganization of Cholinergic Terminals in the Cerebral Cortex and Hippocampus in Transgenic Mice Carrying Mutated Presenilin-1 and Amyloid Precursor Protein Transgenes

The Mouse Brain in Stereotaxic Coordinates

Paxinos, G. (2001) · Cited by 12,859

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627

SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE

DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599

Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

Perry, E., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P., & Perry, R. H. (1978) · British medical journal · doi:10.1136/bmj.2.6150.1457 · Cited by 2,043

Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757

Alzheimer's disease: Targeting the Cholinergic System

H. Ferreira-Vieira, T., M. Guimaraes, I., R. Silva, F., & M. Ribeiro, F. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150716165726 · Cited by 1,551

Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease

Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214

Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies

Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00079-5 · Cited by 678

Alzheimer disease models and human neuropathology: similarities and differences

Duyckaerts, C., Potier, M.-C., & Delatour, B. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0312-8 · Cited by 375

Probing the biology of Alzheimer’s disease in mice

Ashe, K. H., & Zahs, K. R. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.031 · Cited by 413

The history of the cholinergic hypothesis

Contestabile, A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.044 · Cited by 385

Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer’s disease

Kar, S., Slowikowski, S. P. M., Westaway, D. A., & Mount, H. T. J. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0442 · Cited by 366

Locus Ceruleus Degeneration Promotes Alzheimer Pathogenesis in Amyloid Precursor Protein 23 Transgenic Mice

Heneka, M. T., Ramanathan, M., Jacobs, A. H., Dumitrescu-Ozimek, L., Bilkei-Gorzo, A., Debeir, T., Sastre, M., Galldiks, N., Zimmer, A., Hoehn, M., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4236-05.2006 · Cited by 305

Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition

Savage, M. J., Lin, Y.-G., Ciallella, J. R., Flood, D. G., & Scott, R. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03376.2002 · Cited by 291

Glutamatergic systems in Alzheimer's disease

Francis, P. T. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.934 · Cited by 255

Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer’s disease

Urbanc, B., Cruz, L., Le, R., Sanders, J., Ashe, K. H., Duff, K., Stanley, H. E., Irizarry, M. C., & Hyman, B. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222433299 · Cited by 237

Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: A role for intraneuronal amyloid

Giménez‐Llort, L., Blázquez, G., Cañete, T., Johansson, B. A., Oddo, S., Tobeña, A., LaFerla, F. M., & Fernández‐Teruel, A. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.07.007 · Cited by 246

Age-Related Amyloid β Deposition in Transgenic Mice Overexpressing Both Alzheimer Mutant Presenilin 1 and Amyloid β Precursor Protein Swedish Mutant Is Not Associated with Global Neuronal Loss

Takeuchi, A., Irizarry, M. C., Duff, K., Saido, T. C., Hsiao Ashe, K., Hasegawa, M., Mann, D. M. A., Hyman, B. T., & Iwatsubo, T. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64544-0 · Cited by 229

Glaucoma ocular Alzheimer s disease

McKinnon, S. J. (2003) · Frontiers in bioscience · doi:10.2741/1172 · Cited by 229

Age‐related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild‐type mice

Minkeviciene, R., Ihalainen, J. A., Malm, T., Matilainen, O., Keksa-Goldsteine, V., Goldsteins, G., Iivonen, H., Leguit, N., Glennon, J. C., Koıstınaho, J., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05147.x · Cited by 210

Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer’s disease

Liu, Y., Yoo, M.-J., Savonenko, A., Stirling, W., Price, D. L., Borchelt, D. R., Mamounas, L., Lyons, W. E., Blue, M. E., & Lee, M. K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4218-08.2008 · Cited by 206

Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice

Gordon, M. N., King, D. L., Diamond, D. M., Jantzen, P. T., Boyett, K. W., Hope, C. E., Hatcher-Martin, J. M., DiCarlo, G., Gottschall, W. P. E., Morgan, D., et al. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00249-9 · Cited by 199

Reimagining cholinergic therapy for Alzheimer’s disease

Giacobini, E., Cuello, A. C., & Fisher, A. (2022) · Brain · doi:10.1093/brain/awac096 · Cited by 187

Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh

Ole Isacson, A. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02037-4 · Cited by 187

The p75 Neurotrophin Receptor Promotes Amyloid-β(1-42)-Induced Neuritic Dystrophy In Vitro and In Vivo

Knowles, J. K., Rajadas, J., Nguyen, T.-V. V., Yang, T., LeMieux, M. C., Vander Griend, L., Ishikawa, C., Massa, S. M., Wyss-Coray, T., & Longo, F. M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0620-09.2009 · Cited by 184

Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease

Kashani, A., Lepicard, E. M., Poirel, O., Videau, C., David, J. P., Fallet‐Bianco, C., Simon, A., Delacourte, A., Giros, B., Epelbaum, J., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.010 · Cited by 186

The Basal Forebrain Cholinergic Projection System in Mice

Záborszky, L., van den Pol, A. N., & Gyengési, E. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-369497-3.10028-7 · Cited by 173

Modulation of Aβ peptides by estrogen in mouse models

Zheng, H., Xu, H., Uljon, S., Gross, R., Hardy, K. G., Gaynor, J., LaFrancois, J. J., Simpkins, J. W., Refolo, L. M., Petanceska, S. S., et al. (2001) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00690.x · Cited by 175

Basal Forebrain Cholinergic Dysfunction in Alzheimer’s Disease – Interrelationship with β-amyloid, Inflammation and Neurotrophin Signaling

Schliebs, R. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6962-9 · Cited by 167

Cholinergic Changes in the APP23 Transgenic Mouse Model of Cerebral Amyloidosis

Boncristiano, S., Calhoun, M. E., Kelly, P. H., Pfeifer, M., Bondolfi, L., Stalder, M., Phinney, A. L., Abramowski, D., Sturchler-Pierrat, C., Enz, A., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03234.2002 · Cited by 160

Estrogen Signaling in Alzheimer’s Disease: Molecular Insights and Therapeutic Targets for Alzheimer’s Dementia

Uddin, M. S., Rahman, M. M., Jakaria, M., Rahman, M. S., Hossain, M. S., Islam, A., Ahmed, M., Mathew, B., Omar, U. M., Barreto, G. E., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01911-8 · Cited by 156

Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease

Robinson, S. R., & Bishop, G. M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00342-6 · Cited by 155

The Cholinergic Deficit Coincides with Aβ Deposition at the Earliest Histopathologic Stages of Alzheimer Disease

Beach, T. G., Kuo, Y., Spiegel, K., Emmerling, M. R., Sue, L. I., Kokjohn, K., & Roher, A. E. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.4.308 · Cited by 157

Fibrillar β-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer’s disease

Matsuoka, Y., Picciano, M., LaFrancois, J. J., & Duff, K. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00115-4 · Cited by 149

Brain cholinergic vulnerability: Relevance to behavior and disease

McKinney, M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.019 · Cited by 140

Neuregulin-1 and ErbB4 Immunoreactivity Is Associated with Neuritic Plaques in Alzheimer Disease Brain and in a Transgenic Model of Alzheimer Disease

Chaudhury, A. R., Gerecke, K. M., Wyss, J. M., Morgan, D., Gordon, M. N., & Carroll, S. L. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.42 · Cited by 141

Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome

Iulita, M. F., & Cuello, A. C. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.010 · Cited by 141

Extracellular amyloid formation and associated pathology in neural grafts

Meyer‐Luehmann, M., Stalder, M., Herzig, M. C., Kaeser, S. A., Kohler, E., Pfeifer, M., Boncristiano, S., Mathews, P. M., Mercken, M. H., Abramowski, D., et al. (2003) · Nature Neuroscience · doi:10.1038/nn1022 · Cited by 137

The amyloid pathology progresses in a neurotransmitter-specific manner

Bell, K. F. S., Ducatenzeiler, A., Ribeiro‐da‐Silva, A., Duff, K., Bennett, D. A., & Cuello, A. C. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.034 · Cited by 139

Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice

Bellucci, A., Luccarini, I., Scali, C., Prosperi, C., Giovannini, M. G., Pepeu, G., & Casamenti, F. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.03.012 · Cited by 131

Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis

Sanchez-Varo, R. M., Mejias‐Ortega, M., Fernandez-Valenzuela, J. J., Nuñez‐Diaz, C., Cáceres-Palomo, L., Vegas‐Gomez, L., Sánchez‐Mejías, E., Trujillo‐Estrada, L., García‐León, J. A., Moreno‐González, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105404 · Cited by 136

Does my mouse have Alzheimer's disease?

Dodart, J., Mathis, C., Bales, K. R., & Paul, S. M. (2002) · Genes Brain & Behavior · doi:10.1034/j.1601-183x.2002.10302.x · Cited by 126

ADAM-10 over-expression increases cortical synaptogenesis

Bell, K. F. S., Zheng, L., Fahrenholz, F., & Cuello, A. C. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.11.004 · Cited by 129

Age-Related Loss of Synaptophysin Immunoreactive Presynaptic Boutons within the Hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L Transgenic Mice

Rutten, B. P. F., van der Kolk, N. M., Schäfer, S., van Zandvoort, M. A. M. J., Bayer, T. A., Steinbusch, H. W. M., & Schmitz, C. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62963-x · Cited by 117

Cholinergic Involvement in Alzheimer’s Disease. A Link with NGF Maturation and Degradation

Cuello, A. C., Bruno, M. A., Allard, S., León, W., & Iulita, M. F. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9238-z · Cited by 119

Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human β-amyloid precursor protein

Apelt, J., Kumar, A., & Schliebs, R. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03262-6 · Cited by 117

Altered synaptic function in Alzheimer's disease

Bell, K. F. S., & Cuello, A. C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.045 · Cited by 117

Alzheimer’ s disease, oxidative stress and gammahydroxybutyrate

Mamelak, M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.008 · Cited by 108

Amyloid-β Deposition Is Associated with Decreased Hippocampal Glucose Metabolism and Spatial Memory Impairment in APP/PS1 Mice

Sadowski, M., Pankiewicz, J. E., Scholtzova, H., Ji, Y., Quartermain, D., Jensen, C. H., Duff, K., Nixon, R. A., Gruen, R. J., & Wısnıewskı, T. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.5.418 · Cited by 108

Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment

King, D. L., & Arendash, G. W. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03294-2 · Cited by 105

Impact of the NGF Maturation and Degradation Pathway on the Cortical Cholinergic System Phenotype

Allard, S., León, W., Pakavathkumar, P., Bruno, M. A., Ribeiro‐da‐Silva, A., & Cuello, A. C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1144-11.2012 · Cited by 101

Cholinergic neuropathology in a mouse model of Alzheimer's disease

German, D. C., Yazdani, U., Speciale, S. G., Pasbakhsh, P., Games, D., & Liang, C. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10737 · Cited by 101

Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the β-amyloid peptide intracellularly in hippocampal and cortical neurons

Echeverrı́a, V., Ducatenzeiler, A., Dowd, E., Jänne, J., Grant, S. M., Szyf, M., Wandosell, F. G., Ávila, J., Grimm, H. S., Dunnett, S. B., et al. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.036 · Cited by 104

Cholinergic forebrain degeneration in the APPswe/PS1ΔE9 transgenic mouse

Perez, S. E., Dar, S., Ikonomović, M. D., DeKosky, S. T., & Mufson, E. J. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.06.015 · Cited by 100

Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease

Potter, P. E., Rauschkolb, P. K., Pandya, Y., Sue, L. I., Sabbagh, M. N., Walker, D. G., & Beach, T. G. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0831-1 · Cited by 94

Long-term social isolation exacerbates the impairment of spatial working memory in APP/PS1 transgenic mice

Huang, H.-J., Liang, K., Ke, H.-C., Chang, Y.-Y., & Hsieh‐Li, H. M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.043 · Cited by 94

Small Molecule p75NTR Ligands Reduce Pathological Phosphorylation and Misfolding of Tau, Inflammatory Changes, Cholinergic Degeneration, and Cognitive Deficits in AβPPL/S Transgenic Mice

Nguyen, T. V., Shen, L., Griend, L. V., Quach, L. N., Belichenko, N. P., Saw, N. L., Yang, T., Shamloo, M., Wyss‐Coray, T., Massa, S. M., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140036 · Cited by 93

Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity

Weinstock, M., & Shoham, S. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0058-y · Cited by 97

Mice as models: Transgenic approaches and Alzheimer's disease

Games, D., Buttini, M., Kobayashi, D. T., Schenk, D., & Seubert, P. A. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s316 · Cited by 93

Neuropathology of Mice Carrying Mutant APPswe and/or PS1M146L Transgenes: Alterations in the p75NTR Cholinergic Basal Forebrain Septohippocampal Pathway

Jaffar, S., Counts, S., Ma, S. Y., Dadko, E., Gordon, M. N., Morgan, D., & Mufson, E. J. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7710 · Cited by 93

The impact of Aβ-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice

Hu, L., Wong, T. P., Côté, S. L., Bell, K. F. S., & Cuello, A. C. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00394-4 · Cited by 90

Age-dependent disruption in hippocampal theta oscillation in amyloid-β overproducing transgenic mice

Scott, L., Feng, J., Kiss, T., Needle, E., Atchison, K. P., Kawabe, T. T., Milici, A. J., Hajós‐Korcsok, É., Riddell, D. R., & Hajós, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.010 · Cited by 93

Acetylcholinesterase-Positive Fiber Deafferentation and Cell Shrinkage in the Septohippocampal Pathway of Aged Amyloid Precursor Protein London Mutant Transgenic Mice

Bronfman, F. C., Moechars, D., & LEUVEN, F. V. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0283 · Cited by 86

The Role of Hormone Replacement Therapy in the Prevention of Alzheimer Disease

Fillit, H. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.17.1934 · Cited by 87

Nigrostriatal Dysfunction in Familial Alzheimer's Disease-Linked APPswe/PS1ΔE9 Transgenic Mice

Perez, S. E., Lazarov, O., Koprich, J. B., Chen, E., Rodriguez‐Menendez, V., Lipton, J. W., Sisodia, S. S., & Mufson, E. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2773-05.2005 · Cited by 86

Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease

Canas, P. M., Simões, A. P., Rodrigues, R. J., & Cunha, R. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.026 · Cited by 86

Alzheimers Disease: Interactions Between Cholinergic Functions and β- amyloid

Yan, Z., & Feng, J. (2004) · Current Alzheimer Research · doi:10.2174/1567205043331992 · Cited by 84

Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease

Iulita, M. F., Millón, M. B. B., Pentz, R., Aguilar, L. F., Carmo, S. D., Allard, S. T. M., Michalski, B., Wilson, E. N., Ducatenzeiler, A., Bruno, M. A., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.08.019 · Cited by 87

Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice

Perez, S. E., He, B., Muhammad, N., Oh, K.-J., Fahnestock, M., Ikonomovic, M. D., & Mufson, E. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.002 · Cited by 80

Sympathetic Sprouting Drives Hippocampal Cholinergic Reinnervation That Prevents Loss of a Muscarinic Receptor-Dependent Long-Term Depression at CA3–CA1 Synapses

Scheiderer, C. L., McCutchen, E., Thacker, E. E., Kolasa, K., Ward, M. K., Parsons, D. S., Harrell, L. E., Dobrunz, L. E., & McMahon, L. L. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5507-05.2006 · Cited by 78

Intracellular Aβ triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease

Christensen, D. Z., Bayer, T. A., & Wirths, O. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.022 · Cited by 77

Rat transgenic models with a phenotype of intracellular Aβ accumulation in hippocampus and cortex

Echeverrı́a, V., Ducatenzeiler, A., Alhonen, L. I., Jänne, J., Grant, S. M., Wandosell, F. G., Muro, A. F., Baralle, F. E., Li, H., Duff, K., et al. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6301 · Cited by 82

Intracellular and Extracellular Aβ, a Tale of Two Neuropathologies

Cuello, A. C. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00101.x · Cited by 80

Amyloid precursor protein-induced axonopathies are independent of amyloid-β peptides

Stokin, G. B., Almenar-Queralt, A., Gunawardena, S., Rodrigues, E. M., Falzone, T., Kim, J., Lillo, C., Mount, S. L., Roberts, E. A., McGowan, E., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn240 · Cited by 72

Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology

Bell, K. F. S., de Kort, G. J. L., Steggerda, S., Shigemoto, R., Ribeiro‐da‐Silva, A., & Cuello, A. C. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.09.027 · Cited by 70

Oral Administration of Gintonin Attenuates Cholinergic Impairments by Scopolamine, Amyloid-β Protein, and Mouse Model of Alzheimer’s Disease

Kim, H., Shin, E., Lee, B., Choi, S.-H., Jung, S., Cho, I., Hwang, S., Kim, J. Y., Han, J., Chung, C., et al. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0116 · Cited by 67

Aged wild-type and APP, PS1, and APP + PS1 mice present similar deficits in associative learning and synaptic plasticity independent of amyloid load

Gruart, A., López, J. C., Muñoz, M.-D., & Delgado-Garcia, J. M. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.03.001 · Cited by 67

Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer’s disease

Aucoin, J.-S., Jiang, P., Aznavour, N., Tong, X.-K., Buttini, M., Descarries, L., & Hamel, E. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.11.047 · Cited by 66

The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's Disease

Iulita, M. F., & Cuello, A. C. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150921100030 · Cited by 69

Amyloid-Beta Peptide Is Toxic to Neurons In Vivo via Indirect Mechanisms

Walsh, D. T., Montero, R., Bresciani, L. G., Jen, A., Leclercq, P. D., Saunders, D., EL-Amir, A. N., Gbadamoshi, L., Gentleman, S. M., & Jen, L. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0485 · Cited by 70

The role of presenilins in Alzheimer’s disease

Thinakaran, G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8728 · Cited by 65

Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer’s disease

Ubhi, K., Rockenstein, E., Vazquez‐Roque, R., Mante, M., Inglis, C., Patrick, C., Adame, A., Fahnestock, M., Doppler, E., Novak, P., et al. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23142 · Cited by 65

A Rabbit Model of Alzheimer's Disease: Valid at Neuropathological, Cognitive, and Therapeutic Levels

Woodruff‐Pak, D. S., Agelan, A., & Valle, L. D. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11313 · Cited by 64

The Place of Choline Acetyltransferase Activity Measurement in the “Cholinergic Hypothesis” of Neurodegenerative Diseases

Contestabile, A., Ciani, E., & Contestabile, A. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9497-4 · Cited by 64

Tonic Modulation of GABA Release by Nicotinic Acetylcholine Receptors in Layer V of the Murine Prefrontal Cortex

Aracri, P., Consonni, S., Morini, R., Perrella, M., Rodighiero, S., Amadeo, A., & Becchetti, A. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhp214 · Cited by 60

Alteration of cortical EEG in mice carrying mutated human APP transgene

Wang, J., Ikonen, S., Gurevicius, K., van Groen, T., & Tanila, H. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02617-3 · Cited by 62

Comparative analysis of cholinergic innervation in the dorsal hippocampus of adult mouse and rat: A quantitative immunocytochemical study

Aznavour, N., Mechawar, N., & Descarries, L. (2002) · Hippocampus · doi:10.1002/hipo.1108 · Cited by 60

Ginsenoside Re and Rd Enhance the Expression of Cholinergic Markers and Neuronal Differentiation in Neuro-2a Cells

Kim, M. S., Yu, J. M., Kim, H. J., Kim, H. B., Kim, S. T., Jang, S. K., Choi, Y. W., Lee, D. I., & Joo, S. S. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00011 · Cited by 58

Transgenic Mice Overexpressing APP and Transforming Growth Factor-β1 Feature Cognitive and Vascular Hallmarks of Alzheimer's Disease

Ongali, B., Nicolakakis, N., Lecrux, C., Aboulkassim, T., Rosa‐Neto, P., Papadopoulos, P., Tong, X., & Hamel, É. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100339 · Cited by 58

Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes

Hernandez, D., Sugaya, K., Qu, T., McGowan, E., Duff, K., & McKinney, M. (2001) · Neuroreport · doi:10.1097/00001756-200105250-00018 · Cited by 73

Toxicity mediated by soluble oligomers of β‐amyloid(1–42) on cholinergic SN56.B5.G4 cells

Heinitz, K., Beck, M., Schliebs, R., & Perez-Polo, J. R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04015.x · Cited by 58

Stable β-Secretase Activity and Presynaptic Cholinergic Markers During Progressive Central Nervous System Amyloidogenesis in Tg2576 Mice

Gau, J., Steinhilb, M. L., Kao, T.-C., D’Amato, C. J., Gaut, J. R., Frey, K. A., & Turner, R. S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64893-6 · Cited by 56

Transgenic mice expressing the PS1-A246E mutation: effects on spatial learning, exploration, anxiety, and motor coordination

Lalonde, R., Qian, S., & Strazielle, C. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00230-9 · Cited by 54

Quantitative MRI reveals aging‐associated T2 changes in mouse models of Alzheimer's disease

Falangola, M. F., Dyakin, V. V., Lee, P., Bogart, A., Babb, J. S., Duff, K., Nixon, R. A., & Helpern, J. A. (2007) · NMR in Biomedicine · doi:10.1002/nbm.1163 · Cited by 54

Aβ1–42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD

Masliah, E., Alford, M. F., Adame, A., Rockenstein, E. M., Galasko, D., Salmon, D. P., Hansen, L. A., & Thal, L. J. (2003) · Neurology · doi:10.1212/01.wnl.0000073987.79060.4b · Cited by 53

An in vitro and in vivo study of early deficits in associative learning in transgenic mice that over‐express a mutant form of human APP associated with Alzheimer's disease

del Toro, E. D., Moreno, A. R., Porras‐García, E., Sánchez‐Campusano, R., Blanchard, V., Laville, M., Böhme, G. A., Bénavidès, J., & Delgado‐García, J. M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03643.x · Cited by 52

Therapeutic potential of mangiferin in the treatment of various neuropsychiatric and neurodegenerative disorders

Walia, V., Chaudhary, S. K., & Kumar Sethiya, N. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2020.104939 · Cited by 51

The PDAPP mouse model of Alzheimer's disease: Locus coeruleus neuronal shrinkage

German, D. C., Nelson, O. L., Liang, F., Liang, C., & Games, D. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20744 · Cited by 52

Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice

Machová, E., Jakubík, J., Michal, P., Oksman, M., Iivonen, H., Tanila, H., & Doležal, V. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.029 · Cited by 50

Associative and motor learning in 12-month-old transgenic APP+PS1 mice

Ewers, M., Morgan, D., Gordon, M. N., & Woodruff‐Pak, D. S. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.019 · Cited by 50

Automated measurement of nerve fiber density using line intensity scan analysis

Sathyanesan, A. G., Ogura, T., & Lin, W. (2012) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2012.02.019 · Cited by 44

Learning capabilities and CA1-prefrontal synaptic plasticity in a mice model of accelerated senescence

López, J. C., Jurado-Parras, M. T., Sanfeliu, C., Acuña-Castroviejo, D., & Delgado-Garcia, J. M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.005 · Cited by 42

Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice

Hartmann, J., Erb, C., Ebert, U., Baumann, K., Popp, A., König, G., & Klein, J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.02.038 · Cited by 38

Developmental mechanisms in the pathogenesis of neurodegenerative diseases

Mehler, M. F., & Gökhan, Ş. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00052-6 · Cited by 41

Amyloid β peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology

Kar, S., & Quirion, R. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45018-8 · Cited by 37

Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes

Hernandez, D., Sugaya, K., Qu, T., McGowan, E., Duff, K., & McKinney, M. (2001) · Neuroreport · doi:10.1097/00001756-200105250-00018 · Cited by 73

P3‐047: Cholinergic degenerative pathology in ps1m146l/APP751sl alzheimer transgenic model

Trujillo‐Estrada, L., Sánchez‐Mejías, E., Sanchez-Varo, R. M., DeCastro, V., Anerios, M., Torres, M., Jiménez, S., Vizuete, M., Vitórica, J., & Gutiérrez, A. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.1486

Cholinergic Changes in the APP23 Transgenic Mouse Model of Cerebral Amyloidosis

Boncristiano, S., Calhoun, M. E., Kelly, P. H., Pfeifer, M., Bondolfi, L., Stalder, M., Phinney, A. L., Abramowski, D., Sturchler-Pierrat, C., Enz, A., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03234.2002 · Cited by 160

Acetylcholinesterase-Positive Fiber Deafferentation and Cell Shrinkage in the Septohippocampal Pathway of Aged Amyloid Precursor Protein London Mutant Transgenic Mice

Bronfman, F. C., Moechars, D., & LEUVEN, F. V. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0283 · Cited by 86

Neuropathology of Mice Carrying Mutant APPswe and/or PS1M146L Transgenes: Alterations in the p75NTR Cholinergic Basal Forebrain Septohippocampal Pathway

Jaffar, S., Counts, S., Ma, S. Y., Dadko, E., Gordon, M. N., Morgan, D., & Mufson, E. J. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7710 · Cited by 93